women’s health diagnostic testing market is expected to witness an exponential growth over forecast year. The NIH Revitalization Act was formulated in 1993 with a vision to determine the best knowledge about gender and ethnicity differences and similarities and also made women health a national priority. Efforts are now made in order to ensure a healthy lifestyle for women to conform to the laid vision. In terms of healthcare and on a global scale, a high number of women suffer from diseases such as cardiovascular, lung cancer, depression, Alzheimer and urinary contingencies and owing to growth in medical infrastructure across the world and so a higher proportion of women get a timely diagnosis. On the basis of geographic segmentation, the global women’s health diagnostic testing market spans North America, Europe, Middle-East, Asia-Pacific and Africa.
On
a commercial basis, women have distinctive health issues such as menopause,
pregnancy and other minor ailments pertaining to fertility. So, with the rise
in number of female patients for distinct diseases, the market for women’s
health and diagnostic testing market is gaining a positive traction which is
likely to augment the market growth in distant future.
Request Sample Copy of This Market Research @
The
key driving factors responsible for the growth of women’s health diagnostic
testing market include rising awareness in patients with regards to healthcare
concerns, growing research for detection of several type of cancers and
prevention of disease. Additionally, women’s health diagnostic market also
witnesses a significant growth during the forecast period owing to government
initiatives and public awareness campaigns.
Moreover,
the market is rising due to favorable reimbursement of medical policies and
medical coverage for diagnosis & treatment of disorders. However, factors
such as patient’s unwillingness for early screening which need heavy
expenditures for detections, risk over diagnosis and overtreatment, expensive
MRI scans and medicines are likely to impede the market growth during the
forecast period.
On
the basis of tests conducted, the global women’s health diagnostic testing
market is segmented into pregnancy & ovulation, bone density testing,
prenatal screening, mammography, pap smears or cervical cancer screening,
colposcopy, HPV testing, ovarian cancer, urinary tract infections, cystic
fibrosis, and autoimmune diseases. On the basis of prostate cancer screening,
the global women’s health diagnostic testing market is segmented into
hospitals, clinics, home healthcare, research labs, diagnostics and imaging
centers and cancer institutes.
Browse Full Research Report @
https://www.millioninsights.com/industry-reports/womens-health-diagnostic-testing-market
North
America leads the global market owing to advanced healthcare infrastructure,
growth in per-capita income, emphasis on multinational device manufacturing
companies and enhancement of MNC’s. Europe is anticipated to grow during the
forecast period owing to growth in regulations by various medical organizations
such as WHO. Besides, increased funding in public and private sector is
propelling the market growth. APAC regions are anticipated to grow during the
forecast period owing to growth in healthcare scenarios in the regions such as
India and China.
The
key players in the global women’s health diagnostic testing market include Nova
Biomedical, Quest Diagnostics Inc., Abbott Laboratories, GE Healthcare, Alere
Inc., Hologic, Inc.,F. Hoffmann-La Roche AG, Becton, PerkinElmer Inc.,
Dickinson and Company, bioMérieux SA, Koninklijke Philips N.V, Siemens
Healthcare Diagnostics
Comments
Post a Comment